Table 2.
Sociodemographic and clinical variables of the 100 patients included in the study.
| Variables | Number [%] or Mean (S.D) |
|---|---|
| Age | 50.26 (11.11) |
| Gender (=male) | 86 [86] |
| Smoking (Cigarettes/day) | 6.49 (10.50) |
| Duration of CLZ treatment (years) | 15.09 (8.12) |
| CLZ dose (mg/day) | 337.18 (153.69) |
| CLZ plasma levels (ng/mL) | 419.4 (187.08) |
| NCLZ plasma levels (ng/mL) | 253.1 (104.49) |
| Ratio CLZ/NCLZ | 1.69 (0.46) |
| C/D CLZ | 1.422 (0.77) |
| C/D NCLZ | 0.845 (0.41) |
| C/D total | 2.267 (1.13) |
| Wellbeing (SWEMWBS) score | 23.89 (4.66) |
| Genal functioning (GAF) score | 73.18 (11.55) |
| PANSS-positive | 13.26 (4.50) |
| BNSS overall score | 23.00 (15.42) |
|
14.44 (9.27) |
|
8.57 (7.53) |